Jones Jeffrey A, Rawles Robert, Hannun Yusuf A
Molecular and Cellular Biology and Pathobiology Program, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Biochemistry. 2005 Oct 11;44(40):13235-45. doi: 10.1021/bi0505159.
Phosphatidic acid (PA) has been recognized as a lipid second messenger, yet few cellular targets for PA have been identified. Previous work demonstrated PA as a potent and noncompetitive tight-binding inhibitor of the catalytic subunit (gamma isoform) of protein phosphatase-1 (PP1c gamma) in vitro. The high potency of inhibition, coupled with high specificity for PA over other phospholipids, suggested the presence of a high-affinity PA binding domain on PP1c gamma. In the current study, quantification of the binding interaction and identification of the binding domain were pursued. Surface plasmon resonance was employed to quantitate the interaction between PP1c gamma and immobilized mixed lipid vesicles of PA/phosphatidylcholine (PC) or PC alone. The data disclosed a high-affinity interaction with a KD measured in the low (1-40) nanomolar range, consistent with the range of Ki previously obtained from in vitro enzymatic assays. Next, identification of the segment of PP1 necessary for PA binding was determined using a deletion mutagenesis strategy. Binding assays revealed that PP1c gamma residues between 274 and 299 were required for the interaction with the lipid. When fusions of PP1c gamma fragments with green fluorescent protein (GFP) were generated, it was then determined that PP1c gamma residues 286-296 were sufficient to confer PA binding to GFP, a protein that does not interact with PA. The minimal PA binding domain of PP1c gamma lacked similarity to the previously described PA binding segments of Raf-1 kinase and cyclic-AMP phosphodiesterase 4A1. When these results were taken together with the known crystallographic structure of PP1, they identified a novel PA binding region on PP1c gamma that contains a unique loop-strand structural fold responsible for the interaction with PA.
磷脂酸(PA)已被公认为一种脂质第二信使,但PA的细胞靶点却鲜有被发现。先前的研究表明,PA在体外是蛋白磷酸酶-1(PP1cγ)催化亚基(γ亚型)的一种强效非竞争性紧密结合抑制剂。其高抑制效力以及对PA相较于其他磷脂的高特异性,表明PP-1cγ上存在一个高亲和力的PA结合结构域。在本研究中,我们对结合相互作用进行了定量,并确定了结合结构域。采用表面等离子体共振技术来定量PP1cγ与固定化的PA/磷脂酰胆碱(PC)混合脂质囊泡或单独的PC之间的相互作用。数据显示存在高亲和力相互作用,其解离常数(KD)在低纳摩尔范围(1 - 40)内,这与先前从体外酶促测定中获得的抑制常数(Ki)范围一致。接下来,使用缺失诱变策略确定PA结合所需的PP1片段。结合试验表明,PP1cγ中274至299位的残基对于与脂质的相互作用是必需的。当生成PP1cγ片段与绿色荧光蛋白(GFP)的融合体时,随后确定PP1cγ的286 - 296位残基足以使GFP具有PA结合能力,而GFP是一种不与PA相互作用的蛋白质。PP-1cγ的最小PA结合结构域与先前描述的Raf-1激酶和环磷酸腺苷磷酸二酯酶4A1的PA结合片段没有相似性。当将这些结果与已知的PP1晶体结构结合起来时,它们在PP1cγ上确定了一个新的PA结合区域,该区域包含一个独特的环 - 链结构折叠,负责与PA的相互作用。